COMMUNIQUÉS West-GlobeNewswire

National Research Corporation Announces Second Quarter 2019 Results
06/08/2019
LINCOLN, Neb., Aug. 06, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the second quarter of 2019. Net New Sales of $6.1 million up 14% Revenue increased 12% to $31.4 [...]
Supernus Announces Second Quarter 2019 Financial Results
06/08/2019
Total revenue of $104.7 million, a 5.2% increase over 2018 Net product sales of $102.4 million, a 5.5% increase over 2018 Operating earnings of $42.6 million, a 19.3% increase over 2018 Submission of New Drug [...]
Clearside Biomedical to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
ALPHARETTA, Ga., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Denali Therapeutics Reports Second Quarter 2019 Financial Results and Business Highlights
06/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, [...]
Silk Road Medical Announces Proposed Public Offering of Common Stock
06/08/2019
SUNNYVALE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today the [...]
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
06/08/2019
Source: Mesa Laboratories, Inc. – August 6, 2019 4:05 PM ET LAKEWOOD, Colo., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced that it has commenced concurrent [...]
Zafgen to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Dova Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
DURHAM, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Jason Hoitt, Chief Commercial Officer, will present a company overview at the 2019 Wedbush PacGrow [...]
Editas Medicine Announces Second Quarter 2019 Results and Update
06/08/2019
Cynthia (Cindy) Collins named President and Chief Executive Officer Initiated Brilliance Phase 1/2 clinical trial of EDIT-101(AGN-151587) for LCA10 Patient dosing in Brilliance trial on track for 2H19 EDIT-301 for [...]
The Cooper Companies to Participate in the Baird Healthcare Conference
06/08/2019
PLEASANTON, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2019 Global Healthcare Conference in New York, NY, on September 4, 2019. Albert G. White III, [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2019 Financial Results and Increases 2019 Outlook
06/08/2019
MINNEAPOLIS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
06/08/2019
Data presented at American Academy of Neurology and American Headache Society Annual Meetings continue to support eptinezumab’s differentiated clinical profile and impact on quality of life measures Core commercial [...]
Healthcare Veteran Kristine Johnson to Join MRI Interventions' Board of Directors
06/08/2019
IRVINE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) is pleased to announce that B. Kristine Johnson has been appointed to MRI Interventions’ Board of Directors, effective [...]
Codexis Reports Second Quarter 2019 Financial Results
06/08/2019
Product revenue up 68%; R&D revenue spread over wider base of customers and markets Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq [...]
BioCardia Announces Closing of $10.0 Million Public Offering
06/08/2019
SAN CARLOS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the [...]
Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update
06/08/2019
Net cash used in operating and investing activities was $12.2 million in the second quarter and $29.7 million for the first six months of 2019; quarter-end cash and restricted cash position of $402.2 million provides [...]
Turning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results
06/08/2019
FDA Accepts Repotrectinib Recommended Phase 2 Dose Regimen for Registrational TRIDENT-1 Study Two Abstracts Selected for Presentation at the European Society for Medical Oncology (ESMO) Annual Congress Highlighting [...]
MRI Interventions Reports 58% Increase in 2019 Second Quarter Revenue
06/08/2019
Record $2.6 Million Quarterly Revenue and Case Volume IRVINE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) (the “Company”) today announced financial results for its second [...]
TCR² Therapeutics to Participate in Upcoming Conferences in August
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from [...]

Pages